BILIARY EXCRETION OF SOME PENICILLINS, QUATERNARY AMMONIUM COMPOUNDS AND TERTIARY AMINES, INCLUDING ASPECTS ON MECHANISMS FOR THEIR EXCRETION = EXCRETION BILIAIRE DE QUELQUES PENICILLINES, DE DERIVES AMMONIUM ET D'AMINES TERTIAIRES, ET DES ASPECTS DU MECANISME DE LEUR EXCRETIONRYRFELDT A.1973; ACTA PHARMACOL. TOXICOL., SUPPL.; DANEM.; DA. 1973; VOL. 32; NO 3; PP. 7-23; BIBL. 2 P. 1/2Serial Issue

LUNG UPTAKE AND ANTIANAPHYLACTIC EFFETS OF KWD 2131 (A BETA -ADRENERGIC AGONIST) IN PERFUSED GUINEA-PIG LUNGSRYRFELDT A; NILSSON E.1981; ACTA PHARMACOL. TOXICOL.; ISSN 0001-6683; DNK; DA. 1981; VOL. 48; NO 5; PP. 390-396; BIBL. 19 REF.Article

THE PHYSIOLOGICAL DISPOSITION OF IBUTEROL, TERBUTALINE AND ISOPROTERENOL AFTER ENDOTRACHEAL INSTILLATION TO RATS. = LA REPARTITION PHYSIOLOGIQUE DE L'IBUTEROL, DE LA TERBUTALINE ET DE L'ISOPROTERENOL APRES INSTALLATION ENDOTRACHEALE A DES RATSRYRFELDT A; BODIN NO.1975; XENOBIOTICA; G. B.; DA. 1975; VOL. 5; NO 9; PP. 521-529; BIBL. 21 REF.Article

PHYSIOLOGICAL DISPOSITION OF IBUTEROL AND TERBUTALINE IN THE ISOLATED PERFUSED RAT LUNGRYRFELDT A; NILSSON E.1976; ACTA PHARMACOL. TOXICOL.; DANEM.; DA. 1976; VOL. 39; NO 1; PP. 39-45; BIBL. 12 REF.Article

The toxicity of foscarnet (phosphonoformic acid, trisodium salt ; PFA) studied in cultured dog renal tubular cellsWALLIN, A; RYRFELDT, A.Toxicology in vitro. 1995, Vol 9, Num 3, pp 237-244, issn 0887-2333, 7 p.Article

PHYSICO-CHEMICAL MODIFICATION OF LIDOCAINE UPTAKE IN RAT LUNG TISSUEPOST C; ANDERSON RGG; RYRFELDT A et al.1979; ACTA PHARMACOL. TOXICOL.; DNK; DA. 1979; VOL. 44; NO 2; PP. 103-109; BIBL. 17 REF.Article

TRANSPORT AND BINDING OF LIDOCAINE BY LUNG SLICES AND PERFUSED LUNG OF RATSPOST C; ANDERSSON RGG; RYRFELDT A et al.1978; ACTA PHARMACOL. TOXICOL.; DNK; DA. 1978; VOL. 43; NO 2; PP. 156-163; BIBL. 17 REF.Article

WHOLE-BODY AUTORADIOGRAPHY OF DELTA ¹-TETRAHYDROCANNABINOL AND DELTA ** (1(6))-TETRAHYDROCANNABINOL IN MOUSE. PHARMACOKINETIC ASPECTS OF DELTA ¹-TETRAHYDROCANNABINOL AND ITS METABOLITESRYRFELDT A; RAMSAY CH; NILSSON IM et al.1973; ACTA PHARM. SUECICA; SUEDE; DA. 1973; VOL. 10; NO 1; PP. 13-28; BIBL. 28 REF.Serial Issue

PHARMACOKINETIC STUDIES OF A POTENT GLUCOCORTICOID (BUDENOSIDE) IN DOGS BY HIGH-PERFORMANCE LIQUID CHROMATOGRAPHYRYRFELDT A; TONNESSON M; NILSSON E et al.1979; J. STEROID BIOCHEM.; GBR; DA. 1979; VOL. 10; NO 3; PP. 317-324; BIBL. 12 REF.Article

Increased airway responsiveness after skin sensitisation to 3-carene, studied in isolated guinea pig lungsLASTBOM, L; BOMAN, A; CAMNER, P et al.Toxicology (Amsterdam). 2000, Vol 147, Num 3, pp 209-214, issn 0300-483XArticle

Toxicity study of the new glucocorticosteroid budesonide in ratsEKMAN, L; KIHLSTRÖM, I; RYRFELDT, A et al.Arzneimittel-Forschung. 1987, Vol 37, Num 1, pp 37-42, issn 0004-4172Article

Tissue distribution and fate of budesonide in the mouseANDERSSON, P; APPELGREN, L.-E; RYRFELDT, A et al.Acta pharmacologica et toxicologica. 1986, Vol 59, Num 5, pp 392-402, issn 0001-6683Article

Acute lung function impairment by hexamethylene diisocyanate and toluene diisocyanate : A comparative study using isolated guinea pig lungsLASTBOM, L; CAMNER, P; RYRFELDT, A et al.Occupational hygiene (Print). 1999, Vol 5, Num 2, pp 111-120, issn 1061-0251Article

Drug induced esophageal lesions studied in vitroRYRFELDT, A; NORBECK, K; REILAND, S et al.Acta physiologica scandinavica. Supplementum. 1990, Vol 140, Num 592, pp 73-82, issn 0302-2994, 10 p.Conference Paper

Nasal bioavailability and systemic effects of the glucocortocid budesonide in manEDSBACKER, S; ANDERSSON, K.-E; RYRFELDT, A et al.European journal of clinical pharmacology. 1985, Vol 29, Num 4, pp 477-481, issn 0031-6970Article

Hypocalcemia induced by foscarnet (foscavir) infusion in dogsRYRFELDT, A; NORDGREN, T; LUNDSTRÖM, J et al.Fundamental and applied toxicology (Print). 1992, Vol 18, Num 1, pp 126-130, issn 0272-0590Article

Pulmonary disposition of the potent glucocorticoid budesonide, evaluated in an isolated perfused rat lung modelRYRFELDT, A; PERSSON, G; NILSSON, E et al.Biochemical pharmacology. 1989, Vol 38, Num 1, pp 17-22, issn 0006-2952Article

Does airway responsiveness increase after skin sensitisation to 3-carene : a study in isolated guinea pig lungsLASTBOM, L; BOMAN, A; CAMNER, P et al.Toxicology (Amsterdam). 1998, Vol 125, Num 1, pp 59-66, issn 0300-483XArticle

Hexamethylene diisocyanate (HDI)-induced lung impairment : Studies in isolated perfused and ventilated guinea pig lungsLASTBOM, L; SKARPING, G; MOLDEUS, P et al.Pharmacology & toxicology. 1997, Vol 81, Num 2, pp 85-89, issn 0901-9928Article

Kinetics of the epimeric glucocorticoid budesonideRYRFELDT, A; EDSBACKER, S; PAUWELS, R et al.Clinical pharmacology and therapeutics. 1984, Vol 35, Num 4, pp 525-530, issn 0009-9236Article

Biotransformation of the topical glucocorticoids budesonide and beclomethasone 17α,21-dipropionate in human liver and lung homogenateANDERSSON, P; RYRFELDT, A; DRACO, A. B et al.Journal of pharmacy and pharmacology. 1984, Vol 36, Num 11, pp 763-765, issn 0022-3573Article

Toxic effects of some xanthine derivatives with special emphasis on adverse effects on rat testesDAHLBACK, M; HEINTZ, L; RYRFELDT, A et al.Toxicology (Amsterdam). 1984, Vol 32, Num 1, pp 23-35, issn 0300-483XArticle

Amitriptyline-induced loss of tight junction integrity in a human endothelial-smooth muscle cell bi-layer modelDAHLIN, K. L; BOHLIN, K; STRINDLUND, J et al.Toxicology (Amsterdam). 1999, Vol 136, Num 1, pp 1-13, issn 0300-483XArticle

Evidence for the activation of the signal-responsive phospholipase A₂ by exogenous hydrogen peroxideBOYER, C. S; BANNENBERG, G. L; NEVE, E. P. A et al.Biochemical pharmacology. 1995, Vol 50, Num 6, pp 753-761, issn 0006-2952Article

Liver metabolism of budesonide in rat, mouse, and man: comparative aspectsEDSBACKER, S; ANDERSSON, P; LINDBERG, C et al.Drug metabolism and disposition. 1987, Vol 15, Num 3, pp 403-411, issn 0090-9556Article